mortality/aging
• Background Sensitivity: mean age at death is ~350 days on pure 129/Sv background compared to 300 days on mixed background
(J:68981)
• average lifespan is 373 days
(J:68981)
|
neoplasm
• mice develop adenocarcinomas, adenomas, lymphomas, mesotheliomas, angiosarcomas, fibrosarcomas, squamous carcinomas, rectal mucinous adenocarcinomas, melanomas, and papillomas
|
• Background Sensitivity: ~10% of animals develop thymic lymphoma; incidence is lower than on pure 129/Sv background
|
• develop lung adenocarcinomas by 6-8 months of age
• treatment of mice with PX-866, a PI3K inhibitor, decreases lung lesion volume and multiplicity
|
• 4 of 48 mice develop mesothelioma with no occurrence of peritoneal mesothelioma
|
• Background Sensitivity: about 40% of mice develop skin papillomas, with slightly higher incidence than on mixed 129 and C57BL/6 background
|
integument
• Background Sensitivity: about 40% of mice develop skin papillomas, with slightly higher incidence than on mixed 129 and C57BL/6 background
|
respiratory system
• develop lung adenocarcinomas by 6-8 months of age
• treatment of mice with PX-866, a PI3K inhibitor, decreases lung lesion volume and multiplicity
|
• a subset of mutant terminal bronchi contain 4 to 7 bronchioalveolar stem cells (BASCs) compared to 3 of fewer in wild-type bronchi, indicating expansion of BASCs
|
endocrine/exocrine glands
• Background Sensitivity: ~10% of animals develop thymic lymphoma; incidence is lower than on pure 129/Sv background
|
immune system
• Background Sensitivity: ~10% of animals develop thymic lymphoma; incidence is lower than on pure 129/Sv background
|
hematopoietic system
• Background Sensitivity: ~10% of animals develop thymic lymphoma; incidence is lower than on pure 129/Sv background
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
lung cancer | DOID:1324 |
OMIM:211980 OMIM:608935 OMIM:612571 OMIM:612593 OMIM:614210 |
J:68981 , J:136369 |